Literature DB >> 22560555

The abscopal effect associated with a systemic anti-melanoma immune response.

Emily F Stamell1, Jedd D Wolchok, Sacha Gnjatic, Nancy Y Lee, Isaac Brownell.   

Abstract

The clearance of nonirradiated tumors after localized radiation therapy is known as the abscopal effect. Activation of an antitumor immune response has been proposed as a mechanism for the abscopal effect. Here we report a patient with metastatic melanoma who received palliative radiation to his primary tumor with subsequent clearance of all his nonirradiated in-transit metastases. Anti-MAGEA3 antibodies were found upon serological testing, demonstrating an association between the abscopal effect and a systemic antitumor immune response. A brain recurrence was then treated with a combination of stereotactic radiosurgery and immunotherapy with ipilimumab. The patient experienced a complete remission that included resolution of nodal metastases, with a concomitant increase in MAGEA3 titers and a new response to the cancer antigen PASD1. This case supports the immune hypothesis for the abscopal effect, and illustrates the potential of combining radiotherapy and immunotherapy in the treatment of melanoma. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560555      PMCID: PMC3415596          DOI: 10.1016/j.ijrobp.2012.03.017

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Whole body irradiation; radiobiology or medicine?

Authors:  R H MOLE
Journal:  Br J Radiol       Date:  1953-05       Impact factor: 3.039

2.  Melanoma vaccines: possible progress after years of frustration?

Authors:  Charlie Schmidt
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

3.  Malignant melanoma and vitiligo: can radiotherapy shed light on the subject?

Authors:  A Abood; D B Saleh; D A L Watt
Journal:  J Plast Reconstr Aesthet Surg       Date:  2008-10-19       Impact factor: 2.740

4.  Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis.

Authors:  K Ohba; K Omagari; T Nakamura; N Ikuno; S Saeki; I Matsuo; H Kinoshita; J Masuda; H Hazama; I Sakamoto; S Kohno
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

5.  An interesting case of possible abscopal effect in malignant melanoma.

Authors:  D P Kingsley
Journal:  Br J Radiol       Date:  1975-10       Impact factor: 3.039

Review 6.  Imiquimod in the treatment of lentigo maligna.

Authors:  S F Rajpar; J R Marsden
Journal:  Br J Dermatol       Date:  2006-10       Impact factor: 9.302

7.  Vitiligo and malignant melanoma.

Authors:  J Fodor; I Bodrogi
Journal:  Neoplasma       Date:  1975       Impact factor: 2.575

8.  Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.

Authors:  Amit A Lugade; James P Moran; Scott A Gerber; Robert C Rose; John G Frelinger; Edith M Lord
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

9.  Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.

Authors:  Youjin Lee; Sogyong L Auh; Yugang Wang; Byron Burnette; Yang Wang; Yuru Meng; Michael Beckett; Rohit Sharma; Robert Chin; Tony Tu; Ralph R Weichselbaum; Yang-Xin Fu
Journal:  Blood       Date:  2009-04-06       Impact factor: 22.113

10.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.

Authors:  Sandra Demaria; Bruce Ng; Mary Louise Devitt; James S Babb; Noriko Kawashima; Leonard Liebes; Silvia C Formenti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

  10 in total
  162 in total

1.  [Stereotactic radiotherapy augments the immune response].

Authors:  Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2016-01       Impact factor: 3.621

2.  Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

Authors:  Ana P Kiess; Jedd D Wolchok; Christopher A Barker; Michael A Postow; Viviane Tabar; Jason T Huse; Timothy A Chan; Yoshiya Yamada; Kathryn Beal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-05       Impact factor: 7.038

3.  Immunotherapy for Head and Neck Squamous Cell Carcinoma.

Authors:  Rebecca C Hoesli; Jeffrey S Moyer
Journal:  Curr Oral Health Rep       Date:  2016-03-12

Review 4.  The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

Authors:  Kobe Reynders; Tim Illidge; Shankar Siva; Joe Y Chang; Dirk De Ruysscher
Journal:  Cancer Treat Rev       Date:  2015-03-28       Impact factor: 12.111

Review 5.  Strategies for combining immunotherapy with radiation for anticancer therapy.

Authors:  Steven N Seyedin; Jonathan E Schoenhals; Dean A Lee; Maria A Cortez; Xiaohong Wang; Sharareh Niknam; Chad Tang; David S Hong; Aung Naing; Padmanee Sharma; James P Allison; Joe Y Chang; Daniel R Gomez; John V Heymach; Ritsuko U Komaki; Laurence J Cooper; James W Welsh
Journal:  Immunotherapy       Date:  2015-08-27       Impact factor: 4.196

Review 6.  Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.

Authors:  Young Seok Seo; Mi-Sook Kim; Hyung-Jun Yoo; Won-Il Jang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Tumour radiosensitivity is associated with immune activation in solid tumours.

Authors:  Tobin Strom; Louis B Harrison; Anna R Giuliano; Michael J Schell; Steven A Eschrich; Anders Berglund; William Fulp; Ram Thapa; Domenico Coppola; Sungjune Kim; Jessica Frakes; John Foekens; James J Mulé; Javier F Torres-Roca
Journal:  Eur J Cancer       Date:  2017-08-29       Impact factor: 9.162

Review 8.  Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma.

Authors:  Christopher A Barker; Michael A Postow; Shaheer A Khan; Kathryn Beal; Preeti K Parhar; Yoshiya Yamada; Nancy Y Lee; Jedd D Wolchok
Journal:  Cancer Immunol Res       Date:  2013-07-25       Impact factor: 11.151

9.  Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma.

Authors:  E Liniker; A M Menzies; B Y Kong; A Cooper; S Ramanujam; S Lo; R F Kefford; G B Fogarty; A Guminski; T W Wang; M S Carlino; A Hong; G V Long
Journal:  Oncoimmunology       Date:  2016-08-19       Impact factor: 8.110

10.  Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer.

Authors:  Grit S Herter-Sprie; Shohei Koyama; Houari Korideck; Josephine Hai; Jiehui Deng; Yvonne Y Li; Kevin A Buczkowski; Aaron K Grant; Soumya Ullas; Kevin Rhee; Jillian D Cavanaugh; Neermala Poudel Neupane; Camilla L Christensen; Jan M Herter; G Mike Makrigiorgos; F Stephen Hodi; Gordon J Freeman; Glenn Dranoff; Peter S Hammerman; Alec C Kimmelman; Kwok-Kin Wong
Journal:  JCI Insight       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.